Clinical trial
Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal Syndrome in the ICU: a Randomised Controlled Study
NCT02496650 is registered in ClinicalTrials.gov with Bogomolets National Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal Syndrome in the ICU: a Randomised Controlled Study
- Lead sponsor
- Bogomolets National Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- June 30, 2015
- Enrollment
- 70 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol withdrawal state